| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/ICB.2014.16 |
| P8608 | Fatcat ID | release_rwlewrm7ojdqxpjknsiuz347me |
| P698 | PubMed publication ID | 24751614 |
| P5875 | ResearchGate publication ID | 261769450 |
| P50 | author | Martin Whitham | Q57326654 |
| P2093 | author name string | Mark A Febbraio | |
| Martin Pal | |||
| P2860 | cites work | Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance | Q84707922 |
| Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin | Q24299103 | ||
| Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex | Q24306425 | ||
| Principles of interleukin (IL)-6-type cytokine signalling and its regulation | Q24530173 | ||
| B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies | Q24598772 | ||
| Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells | Q27860460 | ||
| Obesity is associated with macrophage accumulation in adipose tissue | Q27860976 | ||
| Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance | Q28131660 | ||
| Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance | Q28166649 | ||
| SOCS proteins: negative regulators of cytokine signaling | Q28216055 | ||
| Transforming growth factor-beta induces development of the T(H)17 lineage | Q28237370 | ||
| Structure and function of a new STAT-induced STAT inhibitor | Q28584775 | ||
| Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms | Q28586863 | ||
| IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer | Q29614594 | ||
| Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function | Q29616104 | ||
| Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters | Q29617381 | ||
| Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB | Q29619314 | ||
| C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus | Q29619398 | ||
| Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes | Q29619621 | ||
| A central role for JNK in obesity and insulin resistance | Q29619778 | ||
| Contraction-induced interleukin-6 gene transcription in skeletal muscle is regulated by c-Jun terminal kinase/activator protein-1 | Q30512877 | ||
| Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding | Q33337750 | ||
| Human IL6 enhances leptin action in mice | Q33628094 | ||
| Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance | Q33941406 | ||
| The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine action. | Q34057877 | ||
| Muscles, exercise and obesity: skeletal muscle as a secretory organ | Q34265667 | ||
| Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. | Q34316238 | ||
| Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. | Q34419957 | ||
| Directing transition from innate to acquired immunity: defining a role for IL-6. | Q34449051 | ||
| IL-6 is not necessary for the regulation of adipose tissue mitochondrial content | Q34512264 | ||
| Alteration of JNK-1 signaling in skeletal muscle fails to affect glucose homeostasis and obesity-associated insulin resistance in mice | Q34562825 | ||
| Muscle as an endocrine organ: focus on muscle-derived interleukin-6. | Q34857249 | ||
| Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. | Q34857481 | ||
| The two faces of IL-6 on Th1/Th2 differentiation | Q34996767 | ||
| Imbalanced gp130-dependent signaling in macrophages alters macrophage colony-stimulating factor responsiveness via regulation of c-fms expression | Q36232742 | ||
| Anti-IL-6 antibody treatment but not IL-6 knockout improves intestinal barrier function and reduces inflammation after binge ethanol exposure and burn injury | Q36699019 | ||
| B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile | Q36729660 | ||
| Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation | Q36747890 | ||
| The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells | Q37061850 | ||
| The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer | Q37080407 | ||
| Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance | Q37088657 | ||
| Contraction and AICAR stimulate IL-6 vesicle depletion from skeletal muscle fibers in vivo | Q37110520 | ||
| Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities | Q37129666 | ||
| Glucagon-like peptide 1 receptor induced suppression of food intake, and body weight is mediated by central IL-1 and IL-6 | Q37218334 | ||
| The role of interleukins in insulin resistance and type 2 diabetes mellitus. | Q37462159 | ||
| The role of JNK proteins in metabolism | Q37814784 | ||
| The pro- and anti-inflammatory properties of the cytokine interleukin-6. | Q37836084 | ||
| Targeting gp130 to prevent inflammation and promote insulin action. | Q38134113 | ||
| Interleukin-6 depletion selectively improves hepatic insulin action in obesity | Q38327645 | ||
| Immunometabolism: an emerging frontier | Q38876919 | ||
| TGF-beta promotes Th17 cell development through inhibition of SOCS3. | Q39950912 | ||
| Transgenic blockade of interleukin 6 transsignaling abrogates inflammation | Q40055031 | ||
| Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase | Q40227253 | ||
| Direct cross-talk of interleukin-6 and insulin signal transduction via insulin receptor substrate-1 in skeletal muscle cells | Q40328526 | ||
| Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. | Q40673661 | ||
| Interleukin-6 induces cellular insulin resistance in hepatocytes | Q40687381 | ||
| IL-6 switches the differentiation of monocytes from dendritic cells to macrophages | Q40819435 | ||
| A stress signaling pathway in adipose tissue regulates hepatic insulin resistance | Q41811449 | ||
| Lipopolysaccharide and proinflammatory cytokines stimulate interleukin-6 expression in C2C12 myoblasts: role of the Jun NH2-terminal kinase | Q42169148 | ||
| Muscle cells challenged with saturated fatty acids mount an autonomous inflammatory response that activates macrophages | Q42359004 | ||
| Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness. | Q42462340 | ||
| Elevated IL-6 expression in CD4 T cells via PKCtheta and NF-kappaB induces Th2 cytokine production | Q42576908 | ||
| Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects | Q42797512 | ||
| Chronic interleukin-6 (IL-6) treatment increased IL-6 secretion and induced insulin resistance in adipocyte: prevention by rosiglitazone. | Q42834547 | ||
| Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action | Q42917991 | ||
| Extramedullary expansion of hematopoietic progenitor cells in interleukin (IL)-6-sIL-6R double transgenic mice | Q42947751 | ||
| Transgenic mice with astrocyte-targeted production of interleukin-6 are resistant to high-fat diet-induced increases in body weight and body fat. | Q43277580 | ||
| Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after prolonged running. | Q43540328 | ||
| Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion | Q43668496 | ||
| Interleukin-6-deficient mice develop mature-onset obesity | Q43851625 | ||
| Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. | Q44424615 | ||
| IL-6 is not essential for exercise-induced increases in glucose uptake. | Q44455523 | ||
| Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice | Q44631827 | ||
| Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity | Q44932358 | ||
| Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction | Q44953893 | ||
| How obesity causes diabetes: not a tall tale | Q45232061 | ||
| Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARalpha and UCP2 expression in rats | Q46560266 | ||
| Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice | Q46663069 | ||
| Obesity promotes liver carcinogenesis via Mcl-1 stabilization independent of IL-6Rα signaling | Q46674674 | ||
| Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior | Q47277520 | ||
| CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. | Q48588727 | ||
| Raised interleukin-6 levels in obese patients | Q48702097 | ||
| Impaired immune and acute-phase responses in interleukin-6-deficient mice. | Q52514391 | ||
| Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. | Q52522262 | ||
| Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. | Q54427494 | ||
| Interleukin-6 modifies mRNA expression in mouse skeletal muscle. | Q54610017 | ||
| Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss | Q56096259 | ||
| IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation | Q56943138 | ||
| Lifetime risk and projected population prevalence of diabetes | Q58007870 | ||
| The anti-CD20 antibody rituximab reduces the Th17 cell response | Q58998900 | ||
| Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running | Q59326390 | ||
| Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle | Q61908396 | ||
| Cutting Edge: Trans-Signaling via the Soluble IL-6R Abrogates the Induction of FoxP3 in Naive CD4+CD25- T Cells | Q62658842 | ||
| A comparative analysis of cytokine production and tolerance induction by bacterial lipopeptides, lipopolysaccharides and Staphyloccous aureus in human monocytes | Q74254660 | ||
| Exercise stimulates c-Jun NH2 kinase activity and c-Jun transcriptional activity in human skeletal muscle | Q77472020 | ||
| The JNK signal transduction pathway | Q79781771 | ||
| Interleukin-6 mediates exercise-induced increase in insulin sensitivity in mice | Q83954187 | ||
| P433 | issue | 4 | |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 331-339 | |
| P577 | publication date | 2014-03-11 | |
| P1433 | published in | Immunology & Cell Biology | Q13731918 |
| P1476 | title | From cytokine to myokine: the emerging role of interleukin-6 in metabolic regulation | |
| P478 | volume | 92 |
| Q41236432 | Acute and chronic effects of exercise on mRNA expression in the skeletal muscle of two mouse models of peripheral artery disease |
| Q95851869 | Adenosine A2B Receptors - Mediated Induction of Interleukin-6 in Skeletal Muscle Cells |
| Q33563621 | Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration |
| Q36058683 | An Integrative Transcriptomic Analysis for Identifying Novel Target Genes Corresponding to Severity Spectrum in Spinal Muscular Atrophy |
| Q92712267 | Anabolic and Pro-metabolic Functions of CREB-CRTC in Skeletal Muscle: Advantages and Obstacles for Type 2 Diabetes and Cancer Cachexia |
| Q42513060 | Anthocyanins from Purple Corn Ameliorated Tumor Necrosis Factor-α-Induced Inflammation and Insulin Resistance in 3T3-L1 Adipocytes via Activation of Insulin Signaling and Enhanced GLUT4 Translocation |
| Q34444895 | Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease |
| Q37298151 | Atorvastatin Therapy Modulates Telomerase Activity in Patients Free of Atherosclerotic Cardiovascular Diseases |
| Q92765039 | Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia |
| Q28081672 | Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance |
| Q38809663 | Brown adipose tissue: The heat is on the heart. |
| Q33741510 | Cardiovascular Response and Serum Interleukin-6 Level in Concentric Vs. Eccentric Exercise |
| Q41039555 | Changes in pro-inflammatory markers and leucine concentrations in response to Nordic Walking training combined with vitamin D supplementation in elderly women |
| Q35870385 | Changes in the cytokine expression of peripheral Treg and Th17 cells in children with rotavirus enteritis |
| Q92963822 | ComBATing aging-does increased brown adipose tissue activity confer longevity? |
| Q28073309 | Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes |
| Q39004711 | Control of Skeletal Muscle Cell Growth and Size Through Adhesion GPCRs |
| Q90678059 | Cytokines and inflammation in adipogenesis: an updated review |
| Q41146515 | Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation |
| Q26823335 | Does Whole Grain Consumption Alter Gut Microbiota and Satiety? |
| Q50532628 | Effect of endurance training and branched-chain amino acids on the signaling for muscle protein synthesis in CKD model rats fed a low-protein diet. |
| Q64067658 | Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes |
| Q26746996 | Epicardial Fat: Physiological, Pathological, and Therapeutic Implications |
| Q33639120 | Exercise and Glycemic Control: Focus on Redox Homeostasis and Redox-Sensitive Protein Signaling |
| Q52905017 | Exercise and its role in gestational diabetes mellitus. |
| Q38271157 | Exercise as an anti-inflammatory therapy for rheumatic diseases-myokine regulation |
| Q53481310 | Exercise-mediated IL-6 signaling occurs independent of inflammation and is amplified by training in mouse adipose tissue. |
| Q36139186 | Factors Associated With Plasma IL-6 Levels During HIV Infection |
| Q90607166 | Factors influencing post-exercise proteinuria after marathon and ultramarathon races |
| Q35998806 | Fighting obesity: When muscle meets fat. |
| Q37724747 | Global mRNA sequencing of human skeletal muscle: Search for novel exercise-regulated myokines |
| Q42060464 | IL-6, Antioxidant Capacity and Muscle Damage Markers Following High-Intensity Interval Training Protocols |
| Q37363333 | Immunometabolic Responses after Short and Moderate Rest Intervals to Strength Exercise with and without Similar Total Volume |
| Q35801533 | Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters |
| Q43660564 | Increased intake of carbohydrates from sources with a higher glycemic index and lower consumption of whole grains during puberty are prospectively associated with higher IL-6 concentrations in younger adulthood among healthy individuals |
| Q41670125 | Inflammatory Cytokines and BDNF Response to High-Intensity Intermittent Exercise: Effect the Exercise Volume. |
| Q91711447 | Inflammatory Signaling and Brown Fat Activity |
| Q33587718 | Interleukin-6 increases the expression and activity of insulin-degrading enzyme. |
| Q41689291 | Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis |
| Q33729970 | Long-lasting effect of obesity on skeletal muscle transcriptome |
| Q33621822 | Low-Dose Pulsatile Interleukin-6 As a Treatment Option for Diabetic Peripheral Neuropathy |
| Q90196428 | MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells |
| Q36211902 | Marathon Race Affects Neutrophil Surface Molecules: Role of Inflammatory Mediators |
| Q35429223 | Muscle as a "mediator" of systemic metabolism |
| Q48010636 | Muscle interleukin-6 and fasting-induced PDH regulation in mouse skeletal muscle |
| Q37249842 | Myokines in Response to a Tournament Season among Young Tennis Players. |
| Q51248524 | No effect of acute and chronic supramaximal exercise on circulating levels of the myokine SPARC. |
| Q38534875 | Pharmacologic Options for the Treatment of Sarcopenia |
| Q38849677 | Posttraumatic stress disorder: A metabolic disorder in disguise? |
| Q47829271 | Potential Role of Humoral IL-6 Cytokine in Mediating Pro-Inflammatory Endothelial Cell Response in Amyotrophic Lateral Sclerosis. |
| Q38739575 | Reduced cancer mortality at high altitude: The role of glucose, lipids, iron and physical activity |
| Q58692657 | Regulation of Energy Expenditure and Brown/Beige Thermogenic Activity by Interleukins: New Roles for Old Actors |
| Q98292008 | Role of Myokines in Myositis Pathogenesis and Their Potential to be New Therapeutic Targets in Idiopathic Inflammatory Myopathies |
| Q45620558 | S100A8/A9 (Calprotectin), Interleukin-6, and C-Reactive Protein in Obesity and Diabetes before and after Roux-en-Y Gastric Bypass Surgery |
| Q50055497 | Septic predictor index: A novel platform to identify thermally injured patients susceptible to sepsis |
| Q37219407 | Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults |
| Q47150171 | Short-Term High- and Moderate-Intensity Training Modifies Inflammatory and Metabolic Factors in Response to Acute Exercise |
| Q26743557 | Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6 |
| Q92226203 | Soluble interleukin-6 receptor in young adults and its relationship with body composition and autonomic nervous system |
| Q90214194 | Systemic Inflammation in the Genesis of Frailty and Sarcopenia: An Overview of the Preventative and Therapeutic Role of Exercise and the Potential for Drug Treatments |
| Q92283850 | Temporal dynamics of immune response following prolonged myocardial ischemia/reperfusion with and without cyclosporine A |
| Q88289734 | The Potential Mechanisms of Exercise-induced Cognitive Protection: A Literature Review |
| Q35561612 | The brown fat secretome: metabolic functions beyond thermogenesis |
| Q38951385 | The ever-expanding myokinome: discovery challenges and therapeutic implications |
| Q47362763 | The role of exercise-induced myokines in regulating metabolism. |
| Q99241345 | The wasting-associated metabolite succinate disrupts myogenesis and impairs skeletal muscle regeneration |
| Q48050118 | Uncoupling Exercise Bioenergetics From Systemic Metabolic Homeostasis by Conditional Inactivation of Baf60 in Skeletal Muscle. |
Search more.